Research Areas
Currently her research interests include genetically engineered exosomes drug delivery system, network pharmacology of Chinese medicine, and precision medication prediction models.
Education
Sep. 2009- Jul. 2015 SOUTHERN MEDICAL UNIVERSITY GUANGZHOU
·Ph.D.
·Major in Pharmacology, School of Pharmaceutical Sciences
·Supervisor: Prof. Dr. Liu Shuwen
Sep. 2005- Jul. 2009 SOUTHERN MEDICAL UNIVERSITY GUANGZHOU
·Bachelor
·Major in Pharmacology, School of Pharmaceutical Sciences
Publications
Kong Y, Gu C, Zhong D, Zhao X, Lin Q, Wang K, Xun T, Yu L*, Liu S*. Celecoxib antagonizes the cytotoxicity of oxaliplatin in human esophageal cancer cells by impairing the drug influx. Eur J Pharm Sci, 2016. 81: p. 137-48. (IF: 3.350)
Kong Y, Wu H, Chen Y, Lai S, Yang Z*, Chen J*. [The mechanism of Tanreqing Injection on the treatment of coronavirus disease 2019 based on network pharmacology and molecular docking]. Chinese Traditional and Herbal Drugs,2020,51(07):1785-1794. (Article in Chinese)
Kong Y, Lin L, Chen Y, Lai S, Wu H*, Chen J*. [Mechanism of XueBiJing Injection on treatment of coronavirus disease 2019 based on Network Pharmacology]. Modernization of Traditional Chinese Medicine and Materia Medical-World science and technology. 2020,22(03):552-560. (Article in Chinese)